Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Ironwood Pharmaceuticals (IRWD) over the last 17 years, with Q3 2025 value amounting to $930000.0.

  • Ironwood Pharmaceuticals' Interest & Investment Income fell 1927.08% to $930000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year decrease of 3048.73%. This contributed to the annual value of $4.5 million for FY2024, which is 7644.83% down from last year.
  • According to the latest figures from Q3 2025, Ironwood Pharmaceuticals' Interest & Investment Income is $930000.0, which was down 1927.08% from $818000.0 recorded in Q2 2025.
  • In the past 5 years, Ironwood Pharmaceuticals' Interest & Investment Income registered a high of $8.8 million during Q2 2023, and its lowest value of $172000.0 during Q2 2021.
  • Moreover, its 5-year median value for Interest & Investment Income was $1.0 million (2022), whereas its average is $1.9 million.
  • In the last 5 years, Ironwood Pharmaceuticals' Interest & Investment Income skyrocketed by 306173.91% in 2023 and then tumbled by 8436.68% in 2024.
  • Quarter analysis of 5 years shows Ironwood Pharmaceuticals' Interest & Investment Income stood at $180000.0 in 2021, then soared by 2925.56% to $5.4 million in 2022, then plummeted by 78.08% to $1.2 million in 2023, then plummeted by 34.84% to $778000.0 in 2024, then increased by 19.54% to $930000.0 in 2025.
  • Its Interest & Investment Income was $930000.0 in Q3 2025, compared to $818000.0 in Q2 2025 and $869000.0 in Q1 2025.